HRSA-23-069: Autism Secondary Data Analysis Research (Autism SDAR)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Health Resources and Services Administration notices from 2022.
Health Resources and Services Administration offered grants of up to $120,000 to nonprofits, state and local governments and tribes. It expected to make about 4 awards worth $480,000 in total. Applications closed on February 13, 2023.
From the official notice on Grants.gov, last changed December 12, 2022. Checked November 7, 2026.
- Award ceiling$120,000
- Total funding$480,000
- Expected awards4
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | November 14, 2022 |
|---|---|
| Deadline | February 13, 2023 |
Who can apply
This opportunity was open to nonprofits, state and local governments and tribes.
All 9 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligible applicants include any public or private entity, including research centers or networks. Faith-based and community-based organizations, tribes, and tribal organizations are eligible to apply. You are required to submit proof of non-profit status as Attachment 5. A foreign applicant will need to be affiliated with a U.S. entity (i.e., university, institution) with a U.S. EIN established and recognized by HRSA to be considered a public or nonprofit institution of higher learning or a public or private nonprofit agency.
Is this a realistic fit?
- Past Autism Collaboration, Accountability, Research, Education, and Support awards averaged $981,155; this notice allows up to $120,000 per award.
- No cost sharing or match is required.
What the grant funds
The purpose of the SDAR program is to support research that analyzes existing national data sets and/or administrative records to answer questions that can improve the health and well-being of MCH populations, including children and teenagers with autism spectrum disorders and other developmental disabilities (ASD/DD). The SDAR program helps researchers use existing data sets to identify new issues, study new research questions, test hypotheses, and determine pathways for intervention. Existing and new public health challenges affecting MCH populations, including children with special health care needs (MCH SDAR) and children and adolescents with ASD/DD (Autism SDAR), require timely, evidence-based responses from programs, policy, and practice. Without sufficient evidence or data, it is hard to develop interventions addressing both existing and new issues. SDAR research projects should help address any of the following HRSA’s Strategic Plan Objectives: • 1.4 Incorporate health equity concepts and measures into programs and policies; • 2.3 Improve the quality, safety, and effectiveness of health services for underserved populations and those in need; and • 2.4 Enhance maternal and child health efforts and reduce disparities in morbidity, mortality, and health outcomes.
Who has won Autism Collaboration, Accountability, Research, Education, and Support grants before
From fiscal 2021 to 2025, Autism Collaboration, Accountability, Research, Education, and Support (93.877) awarded $103 million across 105 grant awards, an average of $981,155 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| University of California, Los Angeles | California | 6 | $8.5 million |
| The Children's Hospital of Philadelphia | Pennsylvania | 4 | $3.5 million |
| University of Wisconsin System | Wisconsin | 3 | $3.4 million |
| University of California, Davis | California | 3 | $2.8 million |
| The Regents of the University of Colorado | Colorado | 2 | $2.2 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-23-069 still open?
No. It closed on February 13, 2023.
Who can apply for Autism Secondary Data Analysis Research (Autism SDAR)?
Health Resources and Services Administration accepted applications from nonprofits, state and local governments and tribes. The notice adds further conditions, so read its eligibility section.
What is the deadline for Autism Secondary Data Analysis Research (Autism SDAR)?
Closed February 13, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $120,000 each. About $480,000 in total across about 4 awards.
Who has won Autism Collaboration, Accountability, Research, Education, and Support grants before?
The largest recipients over five fiscal years were University of California, Los Angeles, The Children's Hospital of Philadelphia, University of Wisconsin System. The program made 105 awards worth $103 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)